* Syneos Health Inc SYNH.OQ SYNH.O is expected to show a
fall
in quarterly revenue when it reports results on May 10.
* The Morrisville North Carolina-based company is expected
to
report a 4.1% decrease in revenue to $1.282 billion from $1.34
billion a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data. The company's guidance on
February 16 2023, for the period ended March 31, was for revenue
between $1.26 billion and $1.31 billion.
* Refinitiv's mean analyst estimate for Syneos Health Inc
is for
earnings of 66 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 8
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.
* Wall Street's median 12-month price target for Syneos
Health Inc
is $40, above its last closing price of $39.72.
The company's guidance on February 16 2023 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between USD1.26 billion and USD148 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 1.20 1.20 1.23 Beat 2.7
Sep. 30 2022 1.32 1.32 1.23 Missed -6.5
Jun. 30 2022 1.20 1.20 1.25 Beat 4.6
Mar. 31 2022 0.95 0.95 1.01 Beat 6.5
Dec. 1.43 1.43 1.48 Beat 3.2
31 2021
Sep. 30 2021 1.17 1.17 1.22 Beat 4.4
Jun. 30 2021 0.95 0.95 0.97 Beat 2.4
Mar. 31 2021 0.74 0.75 0.79 Beat 5.8
This summary was machine generated May 8 at 16:11 GMT. All
figures in US dollars unless otherwise stated